{"date":"2026-09-02","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6847-2026-09-02-1908-1hwjjoi","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"19:08:38","subject":"公告本公司115年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"第37款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-09-02 19:08，「公告本公司115年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-09-02-1908-lmtpip","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"19:08:11","subject":"本公司115年第一次現金增資股款催繳公告","clause":"第44款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-09-02 19:08，「本公司115年第一次現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-09-02-1901-1uhskx3","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"19:01:25","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-09-02 19:01，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-09-02-1843-jgqs6c","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"18:43:38","subject":"公告本公司用於治療圓禿之開發中新藥AC-1101，向衛生福利部食品藥物管理署（TFDA）提出第2a期人體臨床試驗(IND)之申復審查申請。","clause":"第8款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-09-02 18:43，「公告本公司用於治療圓禿之開發中新藥AC-1101，向衛生福利部食品藥物管理署（TFDA）提出第2a期人體臨床試驗(IND」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-09-02-1840-j1vbjh","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"18:40:06","subject":"公告本公司專案發展部主管異動","clause":"第11款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-09-02 18:40，「公告本公司專案發展部主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-09-02-1832-5w5zr","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-09-02","time":"18:32:27","subject":"公告本公司新任醫學暨臨床營運部主管","clause":"第11款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-09-02 18:32，「公告本公司新任醫學暨臨床營運部主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-09-02-1751-11r9s0j","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-09-02","time":"17:51:00","subject":"更正公告本公司資訊處長新任案(職稱誤植更正)","clause":"第8款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-09-02 17:51，「更正公告本公司資訊處長新任案(職稱誤植更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-09-02-1745-wey3oo","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-09-02","time":"17:45:19","subject":"更正本公司115年第二季合併財務報告iXBRL申報資訊之母子公司間業務關係及被投資公司等相關資訊","clause":"第51款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-09-02 17:45，「更正本公司115年第二季合併財務報告iXBRL申報資訊之母子公司間業務關係及被投資公司等相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-09-02-1659-152uy2","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-09-02","time":"16:59:40","subject":"公告本公司獨立董事辭任審計委員會委員","clause":"第6款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-09-02 16:59，「公告本公司獨立董事辭任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-09-02-1654-qrsqda","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-09-02","time":"16:54:12","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-09-02 16:54，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-09-02-1633-6cl7qd","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-09-02","time":"16:33:10","subject":"公告本公司董事會通過設立新加坡子公司","clause":"第51款","fact_date":"2026-09-02","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-09-02 16:33，「公告本公司董事會通過設立新加坡子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}